D L Dexter - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

D L Dexter

Showing results (71-80 of 74) with videos related to

Pageof 8

Sort By:

You have reached the last page of results.This site can display upto 74 results.

Cancer Research|November 1, 1985

Activity of a novel 4-quinolinecarboxylic acid, NSC 368390 [6-fluoro-2-(2'-fluoro-1,1'-biphenyl-4-yl)-3-methyl-4-quinolinecarb oxylic acid sodium salt], against experimental tumorsD L Dexter, D P Hesson, R J Ardecky, et al.

Anti-Cancer Drugs|August 1, 1993

XB596, a promising bis-naphthalimide anti-cancer agentS F Chen, D L Behrens, C H Behrens, et al.

Cancer Research|January 1, 1994

Efficacy of DMP 840: a novel bis-naphthalimide cytotoxic agent with human solid tumor xenograft selectivityR J McRipley, P E Burns-Horwitz, P M Czerniak, et al.

International Journal of Oncology|April 11, 2001

Potentiation of antitumor activity of irinotecan by chemically modified oligonucleotidesS Agrawal, E R Kandimalla, D Yu, et al.

Pageof 8

Search research articles

Showing results (71-80 of 74) with videos related to

Sort By:

Pageof 8

You have reached the last page of results.This site can display upto 74 results.

Cancer Research|November 1, 1985

Anti-Cancer Drugs|August 1, 1993

XB596, a promising bis-naphthalimide anti-cancer agentS F Chen, D L Behrens, C H Behrens, et al.

Cancer Research|January 1, 1994

Efficacy of DMP 840: a novel bis-naphthalimide cytotoxic agent with human solid tumor xenograft selectivityR J McRipley, P E Burns-Horwitz, P M Czerniak, et al.

International Journal of Oncology|April 11, 2001

Potentiation of antitumor activity of irinotecan by chemically modified oligonucleotidesS Agrawal, E R Kandimalla, D Yu, et al.

Pageof 8